Jiva Pharma Inc.
USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).
The verdict
According to USPTO PatentsView, Jiva ranks #32,174 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.
- #32,174
- of 49,997 US assignees by volume
- 8th percentile
- by Innovation Score (21.4/100)
- 9.8
- avg claims per patent
- -67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R32174 · US Corporation #32,174 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #32,174/49,997
- PHOTO-FINISH Jiangsu Hengxin…
- CPC-NARROW C07C · 5 areas
- INNOV-THIN 21.4/100
- CLAIMS-PAR 9.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Jiangsu Hengxin Technology Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Jiva’s 21.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Jiva
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Jiva Pharma · this assignee 21
Jiva Pharma · this assignee
21 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Jiva's Innovation Score is 21.4/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Jiva?
Each dot is one of Jiva’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Jiva’s own 9.8 claims/patent is ABOVE the 8.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Jiva's grants concentrate
Jiva Pharma Inc. is a focused PatentsView assignee: 5 CPC subclasses with 75% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2016. By volume, Jiva sits between Jiangsu Hengxin Technology Co., Ltd. and Johnson Controls Metals and Mechanisms GmbH & Co. KG.
Who files at Jiva's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Jiangsu Hengxin T…
Jiangsu Hengxin Technology Co., Ltd.
8 patents
- Jiangsu Transimag…
Jiangsu Transimage Technology Co., Ltd.
8 patents
- Jina Pharmaceutic…
Jina Pharmaceuticals, Inc.
8 patents
- Jinjiang Beisite…
Jinjiang Beisite Electronic Technology Co., Ltd.
8 patents
- Johann Haltermann
Johann Haltermann Limited
8 patents
- John Evans' Sons…
John Evans' Sons, Incorporated
8 patents
- Johnson Controls…
Johnson Controls Advanced Power Solutions GmbH
8 patents
- Johnson Controls…
Johnson Controls Metals and Mechanisms GmbH & Co. KG
8 patents
- Jiva Pharma ◀
Jiva Pharma Inc.
8 patents
What this shows Jiva holds 8 patents at rank #32,180, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Jiva
By rank, the assignees closest to #32,180 in granted patent volume.
- Jiangsu Hengxin Technology Co., Ltd. #32,176 · 8 patents
- Jiangsu Transimage Technology Co., Ltd. #32,177 · 8 patents
- Jina Pharmaceuticals, Inc. #32,178 · 8 patents
- Jinjiang Beisite Electronic Technology Co., Ltd. #32,179 · 8 patents
- Johann Haltermann Limited #32,181 · 8 patents
- John Evans' Sons, Incorporated #32,182 · 8 patents
- Johnson Controls Advanced Power Solutions GmbH #32,183 · 8 patents
- Johnson Controls Metals and Mechanisms GmbH & Co. KG #32,184 · 8 patents
Leaders in C07C (Acyclic OR Carbocyclic Compounds)
Other assignees with the most granted patents in Jiva's primary technology class.
Jiva's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
21 8th percentile higher than 8% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2017 | 4 | 50.0% |
| 2018 | 1 | 12.5% |
| 2020 | 1 | 12.5% |
| 2021 | 1 | 12.5% |
Which technologies does Jiva Pharma Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Jiva Pharma Inc.'s patent record in context - here's where to go next.
- Jiva Pharma Inc.'s lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 75% of its portfolio - see every assignee active in that class. Explore C07C
- Ranked #32,174 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Jiva Pharma Inc. against Jiangsu Hengxin Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 21.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.